These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36809652)
1. O-glycan structures in apo(a) subunit of human lipoprotein(a) suppresses the pro-angiogenic activity of galectin-1 on human umbilical vein endothelial cells. Kalaivani V; Krishna MS; Kumar AA; Satheesh G; Jaleel A FASEB J; 2023 Mar; 37(3):e22813. PubMed ID: 36809652 [TBL] [Abstract][Full Text] [Related]
2. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression. Tang D; Gao J; Wang S; Ye N; Chong Y; Huang Y; Wang J; Li B; Yin W; Wang D Tumour Biol; 2016 Feb; 37(2):1889-99. PubMed ID: 26323258 [TBL] [Abstract][Full Text] [Related]
4. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling. Huang SW; Lien JC; Kuo SC; Huang TF Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319 [TBL] [Abstract][Full Text] [Related]
8. Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex. Wu MH; Ying NW; Hong TM; Chiang WF; Lin YT; Chen YL Angiogenesis; 2014 Oct; 17(4):839-49. PubMed ID: 24719187 [TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells. Wang L; Feng Y; Xie X; Wu H; Su XN; Qi J; Xin W; Gao L; Zhang Y; Shah VH; Zhu Q EBioMedicine; 2019 May; 43():525-536. PubMed ID: 31060904 [TBL] [Abstract][Full Text] [Related]
10. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway. Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related]
12. Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan. Yu Y; Chen R; Sun Y; Pan Y; Tang W; Zhang S; Cao L; Yuan Y; Wang J; Liu C Acta Biomater; 2018 Apr; 71():510-521. PubMed ID: 29501817 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3. Liu L; Craig AW; Meldrum HD; Marcovina SM; Elliott BE; Koschinsky ML Biochem J; 2009 Mar; 418(2):325-36. PubMed ID: 18821851 [TBL] [Abstract][Full Text] [Related]
14. Raftlin is recruited by neuropilin-1 to the activated VEGFR2 complex to control proangiogenic signaling. Bayliss AL; Sundararaman A; Granet C; Mellor H Angiogenesis; 2020 Aug; 23(3):371-383. PubMed ID: 32274611 [TBL] [Abstract][Full Text] [Related]
16. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo. Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585 [TBL] [Abstract][Full Text] [Related]
17. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs. Chuang IC; Yang CM; Song TY; Yang NC; Hu ML Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173 [TBL] [Abstract][Full Text] [Related]
18. Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma. Zhao L; Chen H; Lu L; Zhao C; Malichewe CV; Wang L; Guo X; Zhang X Life Sci; 2021 Apr; 270():119113. PubMed ID: 33508290 [TBL] [Abstract][Full Text] [Related]
20. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo. Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]